Skip to main content
logo
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
463.04
-4.64 (-0.99%)
Aug 1, 2025, 4:00 PM - Market closed

Revance Therapeutics Revenue by Segment

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Laboratory Products
23.07B23.16B22.94B22.93B23.00B23.04B23.27B23.13B
Laboratory Products Growth
0.32%0.50%-1.41%-0.86%0.74%2.35%12.09%23.93%
Life Sciences Solutions
9.69B9.63B9.50B9.54B9.65B9.98B10.55B11.08B
Life Sciences Solutions Growth
0.38%-3.47%-10.02%-13.90%-18.99%-26.27%-27.89%-28.00%
Analytical Instruments
7.49B7.46B7.31B7.26B7.23B7.26B7.10B6.97B
Analytical Instruments Growth
3.69%2.75%2.96%4.15%5.83%9.65%9.78%10.20%
Speciality Diagnostics
4.55B4.51B4.46B4.41B4.41B4.41B4.42B4.40B
Speciality Diagnostics Growth
3.29%2.43%1.02%0.39%0.39%-7.52%-13.35%-18.45%
Eliminations
-1.91B-1.88B-1.84B-1.80B-1.79B-1.83B-1.92B-2.05B

Operating Income by Segment

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Life Sciences Solutions
3.50B3.50B3.45B3.47B3.42B3.42B3.57B3.73B
Life Sciences Solutions Growth
2.10%2.40%-3.37%-6.97%-19.28%-38.73%-45.50%-49.04%
Laboratory Products
3.08B3.09B3.07B3.23B3.31B3.36B3.39B3.18B
Laboratory Products Growth
-7.01%-7.98%-9.56%1.64%8.67%16.92%34.52%45.91%
Analytical Instruments
1.96B1.96B1.88B1.89B1.89B1.91B1.80B1.72B
Analytical Instruments Growth
3.60%2.52%4.45%10.44%15.98%26.61%27.27%32.95%
Speciality Diagnostics
1.17B1.16B1.15B1.14B1.14B1.12B1.07B1.01B
Speciality Diagnostics Growth
2.72%3.11%7.68%13.43%19.66%9.77%-4.04%-16.46%

Operating Expense Breakdown

Period EndingMar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Selling, General, and Administrative
6.99B7.00B6.83B6.67B6.65B6.57B6.73B6.90B
Selling, General, and Administrative Growth
5.09%6.61%1.43%-3.33%-4.47%-7.83%-7.12%-4.63%
Amortization of Intangibles
1.83B1.95B2.08B2.21B2.28B2.34B2.37B2.38B
Amortization of Intangibles Growth
-19.84%-16.51%-12.25%-6.98%-4.56%-2.38%4.32%13.30%
Research and Development
1.40B1.39B1.34B1.32B1.32B1.34B1.40B1.43B
Research and Development Growth
5.98%3.96%-4.14%-8.16%-9.02%-9.11%-4.82%-2.65%
Restructuring and Other
448.00M379.00M231.00M270.00M376.00M459.00M434.00M383.00M
Restructuring and Other Growth
19.15%-17.43%-46.77%-29.50%67.86%302.63%313.33%325.56%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.